Dialysis in Barbados: The cost of hemodialysis provision at the Queen Elizabeth Hospital

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 16, Issue 5, 2004, Pages 350-355

  Adomakoh, Sara A ^a   Adi, Chudi N ^b   Fraser, Henry S ^a   Nicholson, George D ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b QUEEN ELIZABETH HOSPITAL   (Barbados)

Author keywords

Cost analysis; Costs; Hospital costs.; Renal dialysis

Indexed keywords

HEPARIN; RECOMBINANT ERYTHROPOIETIN;

HEALTH CARE; HEALTH EXPENDITURE; HEALTH SERVICES; HOSPITAL SECTOR;

ARTICLE; BARBADOS; COST BENEFIT ANALYSIS; DIALYSIS; DRUG COST; ECONOMICS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEMODIALYSIS; HOSPITAL MANAGEMENT; HOSPITAL PATIENT; HOSPITAL PURCHASING; HOSPITAL SERVICE; HUMAN; KIDNEY FAILURE; LABORATORY; LAUNDRY; MAJOR CLINICAL STUDY; PREVALENCE; PROCESS OPTIMIZATION; RESOURCE ALLOCATION; VASCULAR ACCESS;

ATLANTIC ISLANDS; ATLANTIC OCEAN; BARBADOS; CARIBBEAN ISLANDS; LESSER ANTILLES; OCEANIC REGIONS; WORLD;

EID: 9244227566     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1020-49892004001100009     Document Type: Article

References (27)

1. Lazarus JM, Denker BM, Owen WF. Haemodialysis. In: Brenner BM, ed. The Kidney. Philadelphia: WB Saunders; 1996. Pp. 2424-506.
2. Levinsky NG. The organization of medical care. Lessons from the Medicare End Stage Renal Disease Program. N Engl J Med. 1993;329(19):1395-9.
3. Evans RW, Blagg CR, Bryan FA. Implications for health care policy. A social and demographic profile of hemodialysis patients in the United States. JAMA 1981;245(5):487-91.
4. Tediosi F, Bertolini G, Parazzini F, Mecca G, Garattini L. Cost analysis of dialysis modalities in Italy. Health Serv Manage Res. 2001;14(1):9-17.
5. Lewis MA, La Forgia GM, Sulvetta MB. Measuring public hospital costs: Empirical evidence form the Dominican Republic. Soc. Sci Med. 1996;43(2):221-34.
6. Drummond MF, Stoddart GL, Torrance GW. Methods for economic evaluation of health care programmes. Oxford: Oxford University Press; 1987.
7. Boyle MH, Torrance GW, Sinclair JC, Horwood SP. A cost analysis of providing neonatal intensive care (NIC) to 500-1499 gram birth weight infants. QSEP Research Report, No. 51. Hamilton Ontario, Canada: Program for Quantitative Studies in Economics and Population; 1982.
8. Sennfalt K, Magnusson M, Calsson P. Comparison of hemodialysis and peritoneal dialysis-a cost-utility analysis. Perit Dial Int. 2002;22(1):39-47.
9. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol. 2002;13 (suppl 1): S37-40.
10. Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J of Kidney Dis. 2002;40(3):611-22.
11. Sisca S, Pizzarelli F. Cost-benefit analysis and choice of dialysis treatment in Italy. Dial Transpl. 2002;31:382-7.
12. Rodriguez-Carmona, Perez Fontan M, Bouza P, Garcia Falcon T, Valdes F. The economic cost of dialysis: a comparison between peritoneal dialysis and in-centre haemodialysis. Adv Perit Dial. 1996;12:93-6.
13. Garella S. Costs of dialysis in the USA. Nephrol Dial Transplant. 1997;12[suppl 1]:10-21.
14. Prichard SS. The costs of dialysis in Canada. Nephrol Dial Transplant. 1997;12[suppl 1]:22-4.
15. Jacobs C. The Cost of dialysis treatments for patients with end stage renal disease in France. Nephrol Dial Transplant. 1997;12:[suppl 1]: 29-32.
16. Peeters P, Rublee D, Just PM, Joseph A. Analysis and interpretation of cost data in dialysis: review of Western European literature. Health Policy. 2000;54(3):209-27.
17. Sehgal AR, Dor A, Tsai AC. Morbidity and cost implications of inadequate hemodialysis. Am J Kidney Dis. 2001;37(6):1223-31.
18. United States Renal Data System: 1999 Annual Data Report. XII: International Comparisons of ESRD therapy. Bethesda, MD: USRDS; 1999.
19. Schena FP. Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy. Kidney Int. 2000;57(suppl 74):S39-S45.
20. Vitullo F. Using Dialysis and Transplantation Registries for regional and small-area epidemiology. G Ital Nefrol, 2003;20(2):151-9.
21. McDonald SP, Russ GR, Kerr PG, Collins JF; Australia and New Zealand Dialysis and Transplant Registry. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry. Am J Kidney Dis. 2002;40(6):1122-31.
22. Iseki K, Tozawa M, Iseki C, Takishita S, Ogawa Y. Demographic trends in the Okinawa Dialysis Study (OKIDS) registry (1971-2000). Kidney Int. 2002;61(2):668-75.
23. Jungers P, Massy Z, Man NK, Labrunie M, Taupin P, Guin E, Landais P. Incidence of end-stage renal disease in Ile de France: a prospective epidemiological survey. Presse Med. 2000;29(11):589-92.
24. Djukanovic L, Radovic M, Bakovic J, Budosan I, Bukvic D, Cveticanin A, et al. Epidemiology of end-stage renal disease and current status of hemodialysis in Yugoslavia. Int J Artif Organs. 2002;25(9):852-9.
25. You J, Hoy W, Zhao Y, Beaver C, Eagar K. End-stage renal disease in the Northern Territory: current and future treatment costs. Med J Aust. 2002;176(10):461-5.
26. Hidai H. Need for an incentive-based reimbursement policy toward quality care for dialysis patient management. Kidney Int. 2000;58(1):363-73.
27. McFarlane PA, Mendelssohn DC. A call to arms: economic barriers to optimal dialysis care. Perit Dial Int. 2000;20(1):7-12.